BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: VanderVeen BN, Murphy EA, Carson JA. The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia. Front Physiol 2020;11:1037. [PMID: 32982782 DOI: 10.3389/fphys.2020.01037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol 2023. [PMID: 36806788 DOI: 10.1038/s41571-023-00734-5] [Reference Citation Analysis]
2 Graca FA, Stephan A, Wang YD, Shirinifard A, Jiao J, Vogel P, Labelle M, Demontis F. Progressive development of melanoma-induced cachexia differentially impacts organ systems in mice. Cell Rep 2023;42:111934. [PMID: 36640353 DOI: 10.1016/j.celrep.2022.111934] [Reference Citation Analysis]
3 Rossi F, Lambertini M, Brunetti N, De Giorgis S, Razeti MG, Calabrese M, Tagliafico AS. Muscle mass loss in breast cancer patients of reproductive age (≤ 45 years) undergoing neoadjuvant chemotherapy. Radiol Med 2023;128:49-57. [PMID: 36536266 DOI: 10.1007/s11547-022-01574-6] [Reference Citation Analysis]
4 VanderVeen BN, Cardaci TD, McDonald SJ, Madero SS, Unger CA, Bullard BM, Enos RT, Velázquez KT, Kubinak JL, Fan D, Murphy EA. Obesity reduced survival with 5-fluorouracil and did not protect against chemotherapy-induced cachexia or immune cell cytotoxicity in mice. Cancer Biol Ther 2022;23:1-15. [PMID: 35968771 DOI: 10.1080/15384047.2022.2108306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Redford SE, Varanasi SK, Sanchez KK, Ayres JS. CD4+ T cells regulate sickness-induced anorexia and fat wasting during a chronic parasitic infection.. [DOI: 10.1101/2022.12.17.520896] [Reference Citation Analysis]
6 Di Girolamo D, Tajbakhsh S. Pathological features of tissues and cell populations during cancer cachexia. Cell Regen 2022;11:15. [DOI: 10.1186/s13619-022-00108-9] [Reference Citation Analysis]
7 Wang Y, An Z, Lin D, Jin W. Targeting cancer cachexia: Molecular mechanisms and clinical study. MedComm 2022;3. [DOI: 10.1002/mco2.164] [Reference Citation Analysis]
8 Tripodi L, Molinaro D, Fortunato F, Mella C, Cassani B, Torrente Y, Farini A. Immunoproteasome Inhibition Ameliorates Aged Dystrophic Mouse Muscle Environment. Int J Mol Sci 2022;23. [PMID: 36498987 DOI: 10.3390/ijms232314657] [Reference Citation Analysis]
9 Chen T, Koh K, Lin KM, Chou C. Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders. IJMS 2022;23:12926. [DOI: 10.3390/ijms232112926] [Reference Citation Analysis]
10 Nihashi Y, Yamamoto M, Shimosato T, Takaya T. Myogenetic Oligodeoxynucleotide Restores Differentiation and Reverses Inflammation of Myoblasts Aggravated by Cancer-Conditioned Medium. Muscles 2022;1:111-120. [DOI: 10.3390/muscles1020012] [Reference Citation Analysis]
11 Mohanty T, Gurjar BP, Yangala SB, Nagarajan U. Immunostimulatory Role of Prebiotics and Probiotics. Prebiotics and Probiotics in Disease Regulation and Management 2022. [DOI: 10.1002/9781394167227.ch7] [Reference Citation Analysis]
12 Deyhle MR, Callaway CS, Neyroud D, D'Lugos AC, Judge SM, Judge AR. Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy. Cells 2022;11:1893. [PMID: 35741022 DOI: 10.3390/cells11121893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hildebrandt W, Keck J, Schmich S, Bonaterra GA, Wilhelm B, Schwarzbach H, Eva A, Bertoune M, Slater EP, Fendrich V, Kinscherf R. Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start? Cells 2022;11. [PMID: 35626644 DOI: 10.3390/cells11101607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Graca FA, Rai M, Hunt LC, Stephan A, Wang Y, Gordon B, Wang R, Quarato G, Xu B, Fan Y, Labelle M, Demontis F. The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-30120-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Amitani M, Oba T, Kiyosawa N, Morikawa H, Chino T, Soma A, Shimizu T, Ohno K, Ono M, Ito T, Kanai T, Maeno K, Ito K. Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09443-1] [Reference Citation Analysis]
16 Dmitriev V, Lyadov V, Lyadova M, Shamanov A. Cancer patients’ constitutional features as a predictor of the efficiency of immunotherapy. Onkol Z im P A Gercena 2022;11:57. [DOI: 10.17116/onkolog20221103157] [Reference Citation Analysis]
17 Fairman CM, Lønbro S, Cardaci TD, Vanderveen BN, Nilsen TS, Murphy AE. Muscle wasting in cancer: opportunities and challenges for exercise in clinical cancer trials. JCSM Rapid Communications 2022;5:52-67. [DOI: 10.1002/rco2.56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Campelj DG, Timpani CA, Rybalka E. Cachectic muscle wasting in acute myeloid leukaemia: a sleeping giant with dire clinical consequences. J Cachexia Sarcopenia Muscle 2021. [PMID: 34879436 DOI: 10.1002/jcsm.12880] [Reference Citation Analysis]
19 Deng M, Vaes RDW, van Bijnen AAJHM, Olde Damink SWM, Rensen SS. Activation of the Complement System in Patients with Cancer Cachexia. Cancers (Basel) 2021;13:5767. [PMID: 34830921 DOI: 10.3390/cancers13225767] [Reference Citation Analysis]
20 Beltrà M, Pin F, Ballarò R, Costelli P, Penna F. Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration. Cells 2021;10:3150. [PMID: 34831373 DOI: 10.3390/cells10113150] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Goodenough CG, Partin RE, Ness KK. Skeletal Muscle and Childhood Cancer: Where are we now and where we go from here. Aging Cancer 2021;2:13-35. [PMID: 34541550 DOI: 10.1002/aac2.12027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Aprile G, Basile D, Giaretta R, Schiavo G, La Verde N, Corradi E, Monge T, Agustoni F, Stragliotto S. The Clinical Value of Nutritional Care before and during Active Cancer Treatment. Nutrients 2021;13:1196. [PMID: 33916385 DOI: 10.3390/nu13041196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
23 Ji LL, Yeo D. Oxidative stress: an evolving definition. Fac Rev 2021;10:13. [PMID: 33659931 DOI: 10.12703/r/10-13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
24 Lim S, Brown JL, Washington TA, Greene NP. Development and progression of cancer cachexia: Perspectives from bench to bedside. Sports Med Health Sci 2020;2:177-85. [PMID: 34447946 DOI: 10.1016/j.smhs.2020.10.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]